Weekly Treatment with SAMiRNA Targeting the Androgen Receptor Ameliorates Androgenetic Alopecia

SAMiRNA-AR68 could be efficiently delivered to human follicle dermal papilla cells and hair follicles, and this treatment decreased the androgen receptor mRNA and protein levels.